DRAFT, DO NOT DISTRIBUTE
S
TAKEHOLDER
P
ANEL ON
A
GENT
D
ETECTION
A
SSAYS
February 3 – 4, 2015
AOAC INTERNATIONAL Headquarters
2275 Research Blvd., Rockville, Maryland, 20850
STAKEHOLDER PANEL AGENDA – FEBRUARY 3, 2014 (Day 1)
I.
Welcome and Introductions (9:00 a.m. – 9:15 a.m.)
E. James Bradford, AOAC Executive Director
II.
Overview of Project (9:15 a.m. -9:35 a.m.)
a.
What, Why, and Timescales -
Matthew Davenport, JHU/APL and SPADA Chair
b.
Review of Work Done -
Matthew Davenport, JHU/APL and SPADA Chair
III.
Educational Overview of AOAC Standards Setting Processes (9:25 a.m. – 9:45 a.m.)
Scott Coates, AOAC Chief Scientific Officer
IV.
Agreement on Concepts and Terminology (9:45 a.m. – 10:45 a.m.)
Scott Coates, AOAC Chief Scientific Officer
V.
Working Group Launch Presentations
a.
Q Fever (11:00 a.m. – 12:00 p.m.)
i.
Overview & Challenges
ii.
Agreement on Fitness for Purpose Statement (See Attachment 1 below)
---LUNCH---
b.
Venezuelan Equine Encephalitis (VEE) (1:00 p.m. – 2:15 p.m.)
i.
Overview
ii.
Agreement on Scope of Work / Fitness for Purpose Statement (Attachment 1)
1.
PCR
2.
Discussion: Development of a single or multiple SMPRs for a combination of
VEE + Western Equine Encephalitis virus + Eastern Equine Encephalitis virus
c.
Staphylococcus Enterotoxin B (SEB) (2:30 p.m. – 3:30 p.m.)
i.
Overview
ii.
Challenges
iii.
Agreement on Fitness for Purpose Statement (Attachment 1)
1.
Protein assay
3:45 – 4:45 p.m.: SPADA EXECUTIVE STEERING PANEL SESSION
70
